Search

Author/Creator Maher, Toby M

52. Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2). Issue 1 (21st May 2019)

Authors:
Maher, Toby M; Kreuter, Michael; Lederer, David J; Brown, Kevin K; Wuyts, Wim; Verbruggen, Nadia; Stutvoet, Simone; Fieuw, Ann; Ford, Paul; Abi-Saab, Walid; Wijsenbeek, Marlies
Journal:
BMJ open respiratory research
Issue:
Volume 6:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

53. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial. Issue 1 (January 2023)

Authors:
Maher, Toby M; Tudor, Veronica A; Saunders, Peter; Gibbons, Michael A; Fletcher, Sophie V; Denton, Christopher P; Hoyles, Rachel K; Parfrey, Helen; Renzoni, Elisabetta A; Kokosi, Maria; Wells, Athol U; Ashby, Deborah; Szigeti, Matyas; Molyneaux, Philip L; Akil, Mohammed; Babalis, Daphne; Chaudhur...
Journal:
Lancet
Issue:
Volume 11:Issue 1(2023)
Page Start:
45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

54. Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial. Issue 11 (5th August 2020)

Authors:
Seibold, James R; Maher, Toby M; Highland, Kristin B; Assassi, Shervin; Azuma, Arata; Hummers, Laura Kathleen; Costabel, Ulrich; von Wangenheim, Ute; Kohlbrenner, Veronika; Gahlemann, Martina; Alves, Margarida; Distler, Oliver
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79:Issue 11(2020)
Page Start:
1478
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

55. Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. Issue 8 (August 2018)

Authors:
Maher, Toby M; van der Aar, Ellen M; Van de Steen, Olivier; Allamassey, Lisa; Desrivot, Julie; Dupont, Sonia; Fagard, Liesbeth; Ford, Paul; Fieuw, Ann; Wuyts, Wim
Journal:
Lancet
Issue:
Volume 6:Issue 8(2018)
Page Start:
627
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

58. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Issue 9 (3rd May 2012)

Authors:
Patel, Amit S; Siegert, Richard J; Brignall, Katherine; Gordon, Patrick; Steer, Sophia; Desai, Sujal R; Maher, Toby M; Renzoni, Elisabetta A; Wells, Athol U; Higginson, Irene J; Birring, Surinder S
Journal:
Thorax
Issue:
Volume 67:Issue 9(2012)
Page Start:
804
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

60. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. (February 2020)

Authors:
Hoffmann-Vold, Anna-Maria; Maher, Toby M; Philpot, Edward E; Ashrafzadeh, Ali; Barake, Rafic; Barsotti, Simone; Bruni, Cosimo; Carducci, Paolo; Carreira, Patricia E; Castellví, Ivan; Del Galdo, Francesco; Distler, Jörg H W; Foeldvari, Ivan; Fraticelli, Paolo; George, Peter M; Griffiths, Bridget; ...
Journal:
Lancet
Issue:
Volume 2:Number 2(2020)
Page Start:
e71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗